Cramer’s lightning round: Buy Canopy Growth over Cronos

Business

Cronos Group: “We spoke yesterday with Constellation Brands and David Kline, the excellent CFO, went over there to run Canopy. So if you’re going to have to buy one it’s going to be Canopy, ’cause that guy has got horse sense.”

EPR Properties: “‘I am quite confident … that EPR is a good buy here.”

Teva Pharmaceutical: “No. We have things like Bristol-Myers. Why do we need Teva when they created Bristol-Myers?”

Maxar Technologies: “I don’t understand this ride … I do not know why this stock has just knocked the doors out.”

CyrusOne: “Stock came down a little. Problems with interest rates and REITs, but it’s a good stock. I like it.”

Ballard Power Systems: “These are pure spec. … Periodically this thing has a very big move, it roars, people think Tesla is going to buy it, whatever. Not for me. Not my cup of tea.” Don’t buy.

Starbucks: “O.K., Starbucks was recommended today and it’s about darned time.”

Disclosure: Cramer’s charitable trust own shares of Starbucks.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Products You May Like

Articles You May Like

U.S. Tax Provisions Driving The Fight Against Climate Change
Towns Where Million-Dollar Homes Are Practically The Norm
Here’s how many people will get student loan forgiveness in each state
European businesses are rethinking their plans for a ‘closed’ China
Ford stock suffers worst day since 2011 after cost warning, shedding $7 billion in market value